Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.

Spitaleri, G

Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours. [electronic resource] - Journal of cancer research and clinical oncology Mar 2013 - 447-55 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

1432-1335

10.1007/s00432-012-1327-7 doi


Adult
Aged
Antibodies, Monoclonal--administration & dosage
Cohort Studies
Cytokines--administration & dosage
Disease Progression
Dose-Response Relationship, Drug
Female
Humans
Male
Middle Aged
Molecular Targeted Therapy--methods
Neoplasms--drug therapy
Recombinant Fusion Proteins--administration & dosage